BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37791376)

  • 1. JNKs protect from cholestatic liver disease progression by modulating Apelin signalling.
    Mohamed MR; Haybaeck J; Wu H; Su H; Bartneck M; Lin C; Boekschoten MV; Boor P; Goeppert B; Rupp C; Strnad P; Davis RJ; Cubero FJ; Trautwein C
    JHEP Rep; 2023 Nov; 5(11):100854. PubMed ID: 37791376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury.
    Cubero FJ; Zoubek ME; Hu W; Peng J; Zhao G; Nevzorova YA; Al Masaoudi M; Bechmann LP; Boekschoten MV; Muller M; Preisinger C; Gassler N; Canbay AE; Luedde T; Davis RJ; Liedtke C; Trautwein C
    Gastroenterology; 2016 Apr; 150(4):968-81. PubMed ID: 26708719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma.
    Cubero FJ; Mohamed MR; Woitok MM; Zhao G; Hatting M; Nevzorova YA; Chen C; Haybaeck J; de Bruin A; Avila MA; Boekschoten MV; Davis RJ; Trautwein C
    Hepatol Commun; 2020 Jun; 4(6):834-851. PubMed ID: 32490320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jnk1 in murine hepatic stellate cells is a crucial mediator of liver fibrogenesis.
    Zhao G; Hatting M; Nevzorova YA; Peng J; Hu W; Boekschoten MV; Roskams T; Muller M; Gassler N; Liedtke C; Davis RJ; Cubero FJ; Trautwein C
    Gut; 2014 Jul; 63(7):1159-72. PubMed ID: 24037431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haematopoietic cell-derived Jnk1 is crucial for chronic inflammation and carcinogenesis in an experimental model of liver injury.
    Cubero FJ; Zhao G; Nevzorova YA; Hatting M; Al Masaoudi M; Verdier J; Peng J; Schaefer FM; Hermanns N; Boekschoten MV; Grouls C; Gassler N; Kiessling F; Muller M; Davis RJ; Liedtke C; Trautwein C
    J Hepatol; 2015 Jan; 62(1):140-9. PubMed ID: 25173965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury.
    Iruzubieta P; Goikoetxea-Usandizaga N; Barbier-Torres L; Serrano-Maciá M; Fernández-Ramos D; Fernández-Tussy P; Gutiérrez-de-Juan V; Lachiondo-Ortega S; Simon J; Bravo M; Lopitz-Otsoa F; Robles M; Ferre-Aracil C; Varela-Rey M; Elguezabal N; Calleja JL; Lu SC; Milkiewicz M; Milkiewicz P; Anguita J; Monte MJ; Marin JJG; López-Hoyos M; Delgado TC; Rincón M; Crespo J; Martínez-Chantar ML
    JHEP Rep; 2021 Jun; 3(3):100276. PubMed ID: 33997750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective role of c-Jun N-terminal kinase-2 (JNK2) in ibuprofen-induced acute liver injury.
    Zoubek ME; Woitok MM; Sydor S; Nelson LJ; Bechmann LP; Lucena MI; Andrade RJ; Bast A; Koek GH; Trautwein C; Cubero FJ
    J Pathol; 2019 Jan; 247(1):110-122. PubMed ID: 30264435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse.
    Cai SY; Ge M; Mennone A; Hoque R; Ouyang X; Boyer JL
    Cell Mol Gastroenterol Hepatol; 2020; 9(4):679-688. PubMed ID: 31887435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Phospho-c-Jun N-Terminal Kinase Expression on hepatocyte Necrosis and Autophagy in the Cholestatic Liver.
    Kwak BJ; Choi HJ; Kim OH; Kim KH; You YK; Lee TY; Ahn J; Kim SJ
    J Surg Res; 2019 Sep; 241():254-263. PubMed ID: 31035140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Apelin-Apelin Receptor Axis Triggers Cholangiocyte Proliferation and Liver Fibrosis During Mouse Models of Cholestasis.
    Chen L; Zhou T; White T; O'Brien A; Chakraborty S; Liangpunsakul S; Yang Z; Kennedy L; Saxena R; Wu C; Meng F; Huang Q; Francis H; Alpini G; Glaser S
    Hepatology; 2021 Jun; 73(6):2411-2428. PubMed ID: 32964473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of hepatic c-Met and gp130 expression is associated with an impaired antibacterial response and higher lethality after bile duct ligation.
    Giebeler A; Brandenburg LO; Kaldenbach M; Erschfeld S; Wasmuth H; Wruck C; Trautwein C; Streetz KL
    Lab Invest; 2012 Dec; 92(12):1726-37. PubMed ID: 22986785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury.
    Shearn CT; Anderson AL; Miller CG; Noyd RC; Devereaux MW; Balasubramaniyan N; Orlicky DJ; Schmidt EE; Sokol RJ
    Hepatol Commun; 2023 Jan; 7(1):e0020. PubMed ID: 36633484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of necroptosis in human and experimental cholestasis.
    Afonso MB; Rodrigues PM; Simão AL; Ofengeim D; Carvalho T; Amaral JD; Gaspar MM; Cortez-Pinto H; Castro RE; Yuan J; Rodrigues CM
    Cell Death Dis; 2016 Sep; 7(9):e2390. PubMed ID: 27685634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase 8 differentially controls hepatocytes and non-parenchymal liver cells during chronic cholestatic liver injury in mice.
    Chaudhary K; Liedtke C; Wertenbruch S; Trautwein C; Streetz KL
    J Hepatol; 2013 Dec; 59(6):1292-8. PubMed ID: 23928400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis.
    Liu R; Li X; Zhu W; Wang Y; Zhao D; Wang X; Gurley EC; Liang G; Chen W; Lai G; Pandak WM; Robert Lippman H; Bajaj JS; Hylemon PB; Zhou H
    Hepatology; 2019 Oct; 70(4):1317-1335. PubMed ID: 30985008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PGC1α deficiency reverses cholestasis-induced liver injury via attenuating hepatic inflammation and promoting bile duct remodeling.
    Li D; Ye C; Liu P; Sun T; Qin Y; Wan X
    Acta Histochem; 2023 Dec; 125(8):152097. PubMed ID: 37813066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of caspase 8 in liver parenchymal cells confers protection against murine obstructive cholestasis.
    Cubero FJ; Peng J; Liao L; Su H; Zhao G; Zoubek ME; Macías-Rodríguez R; Ruiz-Margain A; Reißing J; Zimmermann HW; Gassler N; Luedde T; Liedtke C; Hatting M; Trautwein C
    J Hepatol; 2018 Dec; 69(6):1326-1334. PubMed ID: 30144553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
    Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C
    J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism.
    Li J; Zhu X; Zhang M; Zhang Y; Ye S; Leng Y; Yang T; Kong L; Zhang H
    J Hepatol; 2021 Aug; 75(2):400-413. PubMed ID: 33746084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yes-associated protein regulates the hepatic response after bile duct ligation.
    Bai H; Zhang N; Xu Y; Chen Q; Khan M; Potter JJ; Nayar SK; Cornish T; Alpini G; Bronk S; Pan D; Anders RA
    Hepatology; 2012 Sep; 56(3):1097-107. PubMed ID: 22886419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.